We are delighted to share Volume 2, Issue 3 of RSC Pharmaceutics. Read our new open access journal, publishing crucial research on pharmaceutics, which has the potential to drive real change in worldwide health.
“RSC Pharmaceutics will provide a platform for researchers to showcase their best work in this field and contribute to the advancement of Pharmaceutics. I look forward to promoting this journal and its published research to the community.”
Yvonne Perrie, Editor-in-Chief, RSC Pharmaceutics
Here are a few of the articles featured in our latest issue:
AI-driven innovations in pharmaceuticals: optimizing drug discovery and industry operations
Jaskaran Preet Singh Saini, Ankita Thakur and Deepak Yadav
RSC Pharm., 2025,2, 437-454
https://doi.org/10.1039/D4PM00323C
Catherine Unsworth, Andrew B. Dwyer, Alison C. Savage, James J. Hobson, Jonathan Massam, Tom O. McDonald, Paul Curley, Andrew Owen, Andrew O’Sullivan, Ronan MacLoughlin and Steve P. Rannard
RSC Pharm., 2025,2, 517-526
https://doi.org/10.1039/D5PM00006H
Hitesh Wankhede, Sudha Madhavi Penumaka, Debabrata Mandal, Supada Rojatkar, Vinod Gaikwad and Sharvil Patil
RSC Pharm., 2025,2, 541-552
https://doi.org/10.1039/D5PM00025D
These articles and our future publications are free to access by anyone.
Start reading now
|
RSC Pharmaceutics provides researchers with a platform to publish research in pharmaceutics and advance this field. We are interested in any submission that shares new scientific findings across chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery. |